{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:54:23Z","timestamp":1753358063821},"reference-count":0,"publisher":"Dustri-Verlgag Dr. Karl Feistle","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2021,4,9]]},"DOI":"10.5414\/cp203944","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T09:20:00Z","timestamp":1617960000000},"source":"Crossref","is-referenced-by-count":2,"title":["Comparative efficacy and safety of secukinumab, ixekizumab, and tofacitinib in patients with active psoriatic arthritis showing insufficient response to tumor necrosis factor inhibitors"],"prefix":"10.5414","author":[{"given":"Gwan Gyu","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T09:20:01Z","timestamp":1617960001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dustri.com\/index.php?id=8&artId=187857&doi=10.5414\/CP203944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":0,"alternative-id":["203944"],"URL":"https:\/\/doi.org\/10.5414\/cp203944","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,9]]}}}